Kristoffer Staal Rohrberg

18PUBLICATIONS
226CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyHaematological tumoursCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 10, 2026
Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.

|Jun 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

|Apr 07, 2026
A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

Elena Garralda, Christoph Markert, Victor Moreno

|Mar 09, 2026
First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.

Changhoon Yoo, Carles Fabregat-Franco, Chia-Chi Lin

|Feb 12, 2026
Immune Cell Modulation of Patient-Matched Organoid Drug Response in Precision Cancer Medicine Platform.

Silje Kjølle, Mario Presti, Jéssica de Pina Roque

|Jan 07, 2026
Procedures of data merging in precision cancer medicine: the PRIME-ROSE project.

Henk Van der Pol, Tina Kringelbach, Maria Martin Agudo

Pageof 3

Frequent Collaborators

6 joint publications

Ulrik Lassen

6 joint publications

Ignacio Melero

4 joint publications

Victor Moreno

4 joint publications

Emiliano Calvo